Clinical Trials
213 trialsDOTA-STR-17126
Integrated Haematology and Oncology Network
Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer
Memorial Sloan Kettering Cancer Center
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
Icahn School of Medicine at Mount Sinai
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
Vanderbilt-Ingram Cancer Center
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
WINIT-BC
University of Pennsylvania
Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms
Cedars-Sinai Medical Center
A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer
Vanderbilt-Ingram Cancer Center
DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
M.D. Anderson Cancer Center
Pediatric Reporting of Adult-Onset Genomic Results
Geisinger Clinic
Losartan in Prevention of Radiation-Induced Heart Failure
Massachusetts General Hospital
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer
Thomas Jefferson University
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
H. Lee Moffitt Cancer Center and Research Institute
Breast Cancer PSMA PET
University of Iowa
BreastMRgFUS
University of Utah
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
Ohio State University Comprehensive Cancer Center
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer
Guizhou Provincial People's Hospital
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
University of California, Davis
FES BPET-DBT in Newly Diagnosed Breast Cancer
Abramson Cancer Center at Penn Medicine
Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)
University of Alabama at Birmingham
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Radiopharm Theranostics, Ltd
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
Baylor Research Institute
Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution
Stanford University
CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage
Rutgers, The State University of New Jersey
B-GLUCANCER2
Poitiers University Hospital
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
University of Texas Southwestern Medical Center
Window of Opportunity Study Targeting the Inflammatory Milieu
University of Colorado, Denver
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
University of Alabama at Birmingham
OU-SCC-NCAN
University of Oklahoma
Mirtazapine for Acute and Chronic Post Mastectomy Pain
Assiut University
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
Stony Brook University
A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer.
Shandong Cancer Hospital and Institute
VARTUTRACE
Var2 Pharmaceuticals
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
Mayo Clinic
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
University of Wisconsin, Madison
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
Mayo Clinic
A Study of GC101 TIL in Advanced Breast Cancer (10hospital)
Shanghai Juncell Therapeutics
Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).
Milton S. Hershey Medical Center
Neratinib in Combination With Ruxolitinib in Patients With mTNBC
Baylor Research Institute
Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers
University of Kansas Medical Center
Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
Novartis
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions
UNC Lineberger Comprehensive Cancer Center
PROMETEO
SOLTI Breast Cancer Research Group
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Jonsson Comprehensive Cancer Center
A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
Pure Biologics S.A.
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
Pure Biologics S.A.
ICG and SLN Mapping
University of Wisconsin, Madison
Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)
The University of Texas Health Science Center at San Antonio
Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer
Peking Union Medical College Hospital